ADB-BUTINACA is a synthetic cannabinoid (“K2″/”Spice”) first identified in 2019.
ADB-BUTINACA has been found in powders, pills, and drug residues.
The following information was reported in a September 2021 Massachusetts Public Health Alert:
Samples containing ADB-BUTINACA were detected across three jurisdictions in Massachusetts (Boston, Revere & Lawrence) from April 2021 to August 2021. The samples were sold as dope/heroin/fentanyl or Xanax bars. Nearly all contained fentanyl and 4-fluorofentanyl, a potent fentanyl analogue. ADB-BUTINACA is manufactured in clandestine laboratories and is not cut or packaged
in a standard fashion. Potency varies widely for the end user.
It is difficult to identify ADB-BUTINACA without analytical testing. ADB-BUTINACA typically appears as a beige or yellowish powder and readily blends into other available street drugs. Small quantities of ADB-BUTINACA in a sample make it difficult to identify since other components can mask identifiers such as color, smell, and taste.
Synthetic cannabinoids like ADB-BUTINACA are usually sprayed onto plant material or put into blotter paper and smoked. They can also be vaped or consumed orally. For the ADB-BUTINACA containing samples sold as street dope, people were injecting them. Consumers did not report knowing about the presence of ADB-BUTINACA until after use.
ADB-BUTINACA was also reported in the DEA Tox Report (2021 Q4) in a sample submitted from Kentucky.
« Back to Glossary Index
